Women With Hair Loss Have Been Overlooked for Decades, But New Treatments Are Finally Coming to Market

The hair loss drug pipeline has cracked open after three decades of stagnation, and this time women aren’t an afterthought. Three new treatments are in late-stage clinical trials right now, with real data behind them and timelines that could put options on pharmacy shelves as soon as 2027. Here’s what you need to know.

Why haven’t there been new hair loss drugs for so long?

The FDA approved minoxidil in 1988 and finasteride in 1997, and nothing new for pattern hair loss followed for nearly 30 years. Part of the reason is that developing treatments safe enough for women has been genuinely hard.

Finasteride works by blocking DHT production throughout the body, which is one of the main reasons why it’s never been approved for women. Researchers spent decades searching for mechanisms that could work locally, at the follicle level, without hormonal side effects.

Woman's World Answers

What are early signs of dementia in women? What’s a normal body temperature for my age? What are the warning signs of COPD? Can creatine help with weight loss? What do skid marks in my underwear mean? What are early signs of dementia in women? What’s a normal body temperature for my age? What are the warning signs of COPD? Can creatine help with weight loss? What do skid marks in my underwear mean?

Does Ozempic cause hair loss? How can I avoid medical gaslighting? How can I make sex after menopause more enjoyable? How can I lower my A1C levels naturally? What are some common reasons for hair loss in women? Does Ozempic cause hair loss? How can I avoid medical gaslighting? How can I make sex after menopause more enjoyable? How can I lower my A1C levels naturally? What are some common reasons for hair loss in women?

Powered by

Life

Baldness Breakthrough? This New Drug Could Regrow Hair in 8 Weeks

Hair loss isn’t exclusive to one group of people—as a matter of fact, both men and women and individuals young and old deal with things like hair loss and balding for a number of reasons. Whether it be things like genetics, medication or autoimmune diseases like alopecia, adjusting to the way hair loss alters one’s […]

Which new hair loss treatments were designed for women?

Two of the three drugs were built for women from the start, and the third may also be suitable.

PP405, from Pelage Pharmaceuticals, is a topical small molecule that targets dormant hair follicle stem cells to restart growth at the cellular level rather than just slow loss. Pelage included women in its Phase 2a trial from the beginning, enrolling 78 men and women across diverse skin and hair types. No systemic absorption was detected, and Phase 3 trials are planned for 2026.

VDPHL01, from Veradermics, is a non-hormonal extended-release oral minoxidil tablet engineered to avoid the cardiovascular risks of immediate-release oral minoxidil. Veradermics is actively recruiting women for its dedicated Phase 3 Study 306 right now.

Clascoterone 5 percent, from Cosmo Pharmaceuticals, blocks DHT directly at the follicle without entering the bloodstream. Because it stays local, researchers believe it may be appropriate for women with pattern hair loss even though the completed Phase 3 trials enrolled only men.

Beauty

What to Know Before Starting a Hair Regrowth Treatment

If you’re somewhere in your late 30s to early 50s and you’ve started spotting more hair in your brush, on your pillow, or circling the shower drain, you are not imagining things. Hair loss in women is far more common than most people talk about, and far more nuanced than the conversation around men’s hair […]

What do the clinical results show so far?

Clascoterone has the most Phase 3 data behind it. The SCALP 1 and SCALP 2 trials enrolled 1,465 men across the US and Europe, the largest Phase 3 program ever run for a topical AGA treatment. A December 2025 press release from Cosmo Pharmaceuticals reported that SCALP 1 showed a 539 percent relative improvement in target-area hair count versus placebo and SCALP 2 showed 168 percent, with a favorable safety profile across both studies.

VDPHL01’s Phase 2/3 Study 302, with topline results released April 27, 2026, met all primary and key secondary endpoints with robust hair growth in both once-daily and twice-daily arms.

PP405 is earlier in development. Its Phase 2a results showed a significant clinical response in men with higher-degree hair loss by week 8 of observation. Consumer excitement around PP405 is currently running ahead of what the clinical data fully supports, so it’s worth keeping expectations grounded.

When will any of these treatments actually be available?

Clascoterone is furthest along. FDA and EU regulatory submissions are underway following 12-month safety follow-up completion in spring 2026, putting it on track for a potential 2027 approval.

VDPHL01 is targeting an NDA submission in early 2027 with estimated availability in late 2027 to early 2028. Phase 3 Study 304 data in men is expected in the second half of 2026, and the women’s trial is still recruiting.

PP405 is entering Phase 3 in 2026, which puts it furthest from market of the three.

Wellness

Best Hair Loss Treatment for Women, From Natural Fixes to Drugstore Finds

If your ponytail feels a little thinner or your scalp seems more visible lately, you’re not imagining things. Hair loss, thinning and shedding becomes increasingly common with age, and menopause is a top culprit. The good news? There are plenty of affordable hair loss treatment options for women—from drugstore finds to DIY kitchen remedies—that can […]

What can you do for hair loss right now while you wait?

Deal of the Day

This Deep Conditioning Collagen Hair Mask for Has 4.9 Stars and Is 80% Off — Get It for $20! View Deal

You don’t have to wait on the pipeline to take action. Topical minoxidil is the most accessible starting point for both women and men, and a dermatologist can evaluate whether off-label oral minoxidil makes sense for your situation.

Red light therapy, also called low-level laser therapy, works through a completely different mechanism than any of these drugs and can be layered on top of whatever you’re already using.

A 2026 12-month prospective trial in Dermatologic Therapy found sustained improvements in hair density over a full year for pattern hair loss, with additive effects when laser therapy was combined with minoxidil. At-home FDA-cleared devices make it easy to build into a daily routine, and represent one of the most evidence-backed things you can start right now while the next generation of hair loss drugs moves toward approval.